严重无症状大动脉狭窄症的管理:更新的概述
Christophe Tribouilloy1, Yohann Bohbot1, Dan Rusinaru1
1Department of Cardiology, Amiens University Hospital, 80054 Amiens, France; UR UPJV 7517, Jules-Verne University of Picardie, 80054 Amiens, France.
Archives of cardiovascular diseases
|February 16, 2026
概括
大动脉狭窄的管理是复杂的,特别是在无症状患者. 早期干预可能有利于选定的个体,但仔细评估风险和共同决策对于最佳结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 膜心脏疾病 膜心脏疾病
- 老年心脏病学 老年心脏病学
背景情况:
- 大动脉狭窄是老年人中最常见的膜心脏病.
- 没有任何医学治疗可以阻止其进展;大动脉置换是唯一的治疗方法.
- 无症状患者的管理存在挑战,因为突然死亡的风险与程序并发症的风险.
研究的目的:
- 审查目前对主动脉狭窄的管理策略,特别是在无症状患者.
- 突出功能评估和准确严重程度评估的重要性.
- 讨论现代风险分层和早期干预的作用.
主要方法:
- 审查目前关于主动脉狭窄管理的指导方针和文献.
- 强调回声心电图用于严重性评估.
- 功能测试 (练习测试) 和风险分层标记的整合.
主要成果:
- 功能评估确定了"虚假无症状"患者,他们可以从及时干预中受益.
- 早期的大动脉置换显示了关于生存益处的混合结果,但减少了住院治疗.
- 目前的指导方针建议对有症状的患者或射出分数减少的患者进行干预,对低风险的无症状患者进行选择性早期干预.
结论:
- 在多学科的心脏门团队中,共享决策至关重要.
- 考虑患者的偏好,并发症和生活方式至关重要.
- 通过定期测试进行密切的随访,可以优化大动脉狭窄患者的时间和结果.
相关概念视频
Mitral Stenosis III: Medical Management
319
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
319
Aortic Regurgitation III: Medical Management
477
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
477
Mitral Stenosis IV: Nursing Management
300
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
Aneurysm III: Interprofessional Care
326
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
326
Aortic Regurgitation I: Introduction
756
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
756
Atherosclerosis III: Management
460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460


